Healthcare - Medical - Devices - NASDAQ - US
$ 1.85
8.19 %
$ 3.37 M
Market Cap
-0.07
P/E
BALANCE SHEET
98.3 M
ASSETS
29.2 M
LIABILITIES
69.1 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Talis Biomedical Corporation
| Current Assets | 77.7 M |
| Cash & Short-Term Investments | 76.7 M |
| Receivables | 50 K |
| Other Current Assets | 901 K |
| Non-Current Assets | 17 M |
| Long-Term Investments | 1.54 M |
| PP&E | 15.4 M |
| Other Non-Current Assets | 0 |
| Current Liabilities | 8.77 M |
| Accounts Payable | 1.34 M |
| Short-Term Debt | 5.76 M |
| Other Current Liabilities | 1.67 M |
| Non-Current Liabilities | 20.5 M |
| Long-Term Debt | 16.8 M |
| Other Non-Current Liabilities | 3.67 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 76.7 | 130.2 | 232.5 | 138.5 | 21.6 | 6.9 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 50 K | 0.3 | 0.2 | 0.5 | 1.8 | 2.0 |
| Inventory | 0 | 0 | 0 | 46.7 | 0 | 0 |
| Other Current Assets | 0.9 | 2.8 | 3.4 | 49.8 | 0.7 | 0.4 |
| Total Current Assets | 77.7 | 133.3 | 236.1 | 188.7 | 24.1 | 9.3 |
| PP&E | 15.4 | 34.2 | 23.4 | 9.7 | 1.5 | 1.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 1.5 | 1.8 | 0.8 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 1.8 | 5.5 | 0 | 91 K | 0.2 |
| Other Assets | 3.7 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 98.3 | 169.3 | 265.8 | 198.4 | 25.7 | 11.4 |
| LIABILITIES | ||||||
| Accounts Payable | 1.3 | 3.8 | 5.1 | 4.9 | 1.6 | 1.5 |
| Short Term Debt | 5.8 | 7.4 | 2.5 | 1.4 | 0 | 0 |
| Other Current Liabilities | 1.7 | 1.5 | 11.5 | 9.7 | 2.5 | 1.6 |
| Total Current Liabilities | 8.8 | 12.7 | 19.1 | 16.0 | 4.0 | 3.4 |
| Long Term Debt | 16.8 | 29.9 | 12.7 | 0 | 0 | 0 |
| Deferred Tax Income | 3.7 | 7.5 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 290.9 | 42.8 | 59.7 |
| Total Liabilities | 29.2 | 42.6 | 31.9 | 307.0 | 46.9 | 63.4 |
| EQUITY | ||||||
| Common Stock | 0 | 3 K | 3 K | 0 | 0 | 0 |
| Retained Earnings | (540.0) | (478.0) | (364.9) | (172.9) | (81.8) | (54.3) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 | (1.5) |
| Total Equity | 69.1 | 126.7 | 234.0 | (108.6) | (21.1) | (52.0) |
| Total Liabilities and Equity | 98.3 | 169.3 | 265.8 | 198.4 | 25.7 | 11.4 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 1.8 | 1.8 | 1.5 | 0.3 | 0.1 | 0.2 |